ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021
A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Homophily within and across groups.Nature communications · 2025Article
- Impact of interventions to reduce nosocomial transmission of SARS-CoV-2 in English NHS Trusts: a computational modelling study.BMC infectious diseases · 2024Article
- Sorting out assortativity: When can we assess the contributions of different population groups to epidemic transmission?PloS one · 2024Article
- AI-Based Chest CT Analysis for Rapid COVID-19 Diagnosis and Prognosis: A Practical Tool to Flag High-Risk Patients and Lower Healthcare Costs.Diagnostics (Basel, Switzerland) · 2022Article
- Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.Emerging infectious diseases · 2022Article
- Contributions of modelling for the control of COVID-19 nosocomial transmission.Anaesthesia, critical care & pain medicine · 2022Article
- Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study.BMC infectious diseases · 2022Article
- Bayesian Inference of State-Level COVID-19 Basic Reproduction Numbers across the United States.Viruses · 2022Article
- Nanostructured sensor platform based on organic polymer conjugated to metallic nanoparticle for the impedimetric detection of SARS-CoV-2 at various stages of viral infection.Journal of pharmaceutical and biomedical analysis · 2021Article
- Review
- Assessing the impact of data-driven limitations on tracing and forecasting the outbreak dynamics of COVID-19.Computers in biology and medicine · 2021Article
- Mitigating COVID-19 outbreaks in workplaces and schools by hybrid telecommuting.PLoS computational biology · 2021Article
- Assessment of basic reproduction number (RInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021Article
- Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.Clinical microbiology reviews · 2021Review
- COVID-19 in China: Risk Factors and RActa tropica · 2021Article
- Optimizing COVID-19 surveillance in long-term care facilities: a modelling study.BMC medicine · 2020Article
- COVID-19 and medical education: an opportunity to build back better.Ghana medical journal · 2020Article
- Rapid response to crisis: Health system lessons from the active period of COVID-19.Health policy and technology · 2020Article
- Agile response to the shortage of personal protective equipment during the COVID-19 crisis.Clinics (Sao Paulo, Brazil) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To date, no specific estimate of R0 for SARS-CoV-2 is available for healthcare settings. Using interindividual contact data, we highlight that R0 estimates from the community cannot translate directly to healthcare settings, with pre-pandemic R0 values ranging 1.3-7.7 in 3 illustrative healthcare institutions. This has implications for nosocomial COVID-19 control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.